A Study of Staccato Loxapine (ADASUVE®) for Inhalation

Clinical trial NCT04148963 · UNKNOWN

Trial details

NCT number: NCT04148963
Sponsor: Lee's Pharmaceutical Limited
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Psychomotor Agitation Schizophrenia Bipolar Disorder

Start date: 2019-12-01
Primary completion: 2020-05-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.